Pharmacokinetics and dosage adjustment in patients with renal dysfunctionVERBEECK, Roger K; MUSUAMBA, Flora T.European journal of clinical pharmacology. 2009, Vol 65, Num 8, pp 757-773, issn 0031-6970, 17 p.Article

Dose-banding of cytotoxic drugs : A new concept in cancer chemotherapyPLUMRIDGE, Richard J; SEWELL, Graham J.American journal of health-system pharmacy. 2001, Vol 58, Num 18, pp 1760-1764, issn 1079-2082Article

Bayesian individualization via sampling-based methodsWAKEFIELD, J.Journal of pharmacokinetics and biopharmaceutics. 1996, Vol 24, Num 1, pp 103-131, issn 0090-466XArticle

A system-approach method for the adjustment of time-varying continuous drug infusion in individual patients: A simulation studyDURISOVA, Maria; DEDIK, Ladislav.Journal of pharmacokinetics and pharmacodynamics (Print). 2002, Vol 29, Num 5-6, pp 427-444, issn 1567-567X, 18 p.Article

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunctionVERBEECK, Roger K.European journal of clinical pharmacology. 2008, Vol 64, Num 12, pp 1147-1161, issn 0031-6970, 15 p.Article

Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: Simple or complex pharmacokinetic methods?TOD, Michel M; PADOIN, Christophe; PETITJEAN, Olivier et al.Clinical pharmacokinetics. 2001, Vol 40, Num 11, pp 803-814, issn 0312-5963Article

A comparative study of some approaches for estimating tolerance limitsPETZOLD, Max.Drug information journal. 2001, Vol 35, Num 3, pp 1013-1018, issn 0092-8615Conference Paper

Evaluation de l'intérêt du Suivi Thérapeutique Pharmacologique = Issues in Therapeutic Drug Monitoring validationPAINTAUD, G; LE GUELLEC, C; FURET, Y et al.Thérapie (Paris). 2001, Vol 56, Num 3, pp 245-249, issn 0040-5957Conference Paper

Quantification of lean bodyweightJANMAHASATIAN, Sarayut; DUFFULL, Stephen B; ASH, Susan et al.Clinical pharmacokinetics. 2005, Vol 44, Num 10, pp 1051-1065, issn 0312-5963, 15 p.Article

A quel moment introduire le Suivi Thérapeutique Pharmacologique dans une thérapeutique émergente ? = Therapeutic Drug Monitoring for a new drug : when to start?DIQUET, B.Thérapie (Paris). 2001, Vol 56, Num 3, pp 257-260, issn 0040-5957Conference Paper

Statistical analysis of heterogeneous pharmacokinetic data from the literatureZELLNER, D; FRANKEWITSCH, T; SIMON, S et al.European journal of clinical chemistry and clinical biochemistry. 1996, Vol 34, Num 7, pp 585-589, issn 0939-4974Article

Outcomes of Dosage Adjustments Used to Manage Antiretroviral Drug InteractionsPARK-WYLLIE, Laura Y; LEVINE, Mitchell A; HOLBROOK, Anne et al.Clinical infectious diseases. 2007, Vol 45, Num 7, pp 933-936, issn 1058-4838, 4 p.Article

Patient-specific factors predictive of warfarin dosage requirementsABSHER, Randall K; MOORE, M. Elisabeth; PARKER, Mary H et al.The Annals of pharmacotherapy. 2002, Vol 36, Num 10, pp 1512-1517, issn 1060-0280, 6 p.Article

Schéma simple d'adaptation posologique de la fluindione chez les patients âgés = Determination of regimen fluindione needed for anticoagulation in the elderlyLECHOWSKI, L; TEILLET, L; HARBOUN, M et al.La Revue de médecine interne (Paris). 2002, Vol 23, Num 12, pp 1022-1026, issn 0248-8663, 5 p.Article

Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the communityHOLDEN, J; HOLDEN, K.Journal of clinical pharmacy and therapeutics (Print). 2000, Vol 25, Num 1, pp 49-54, issn 0269-4727Article

Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipientsBELITSKY, P; DUNN, S; JOHNSTON, A et al.Clinical pharmacokinetics. 2000, Vol 39, Num 2, pp 117-125, issn 0312-5963Article

Circulatory concentrations of fibrinolytic species during thrombolytic therapy estimated by stirred-tank reactor analysisTULIANI, V. V; O'REAR, E. A.Pharmaceutical research. 1997, Vol 14, Num 8, pp 1051-1057, issn 0724-8741Article

Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) studyJANUS, N; LAUNAY-VACHER, V; MOTTE, G et al.Annals of oncology. 2013, Vol 24, Num 2, pp 501-507, issn 0923-7534, 7 p.Article

Prevalence of renal insufficiency in breast cancer patients and related pharmacological issuesLAUNAY-VACHER, Vincent; GLIGOROV, Joseph; BEUZEBOC, Philippe et al.Breast cancer research and treatment. 2010, Vol 124, Num 3, pp 745-753, issn 0167-6806, 9 p.Article

Bayesian Estimation of Pharmacokinetic Parameters of Vancomycin in Patients with Decreasing Renal FunctionYAMAMOTO, Takehito; TERAKAWA, Hirokazu; HISAKA, Akihiro et al.Journal of pharmaceutical sciences. 2012, Vol 101, Num 8, pp 2968-2975, issn 0022-3549, 8 p.Article

Rapamycin for Focal Segmental Glomerulosclerosis: A Report of 3 CasesTSAGALIS, George; PSIMENOU, Erasmia; ILIADIS, Athanasios et al.American journal of kidney diseases. 2009, Vol 54, Num 2, pp 340-344, issn 0272-6386, 5 p.Article

Lithium Dosing and Serum Concentrations Across the Age Spectrum: From Early Adulthood to the Tenth Decade of LifeREJ, Soham; BEAULIEU, Serge; SEGAL, Marilyn et al.Drugs & aging. 2014, Vol 31, Num 12, pp 911-916, issn 1170-229X, 6 p.Article

L'hyponatrémie modérée potentiellement médicamenteuse du sujet âgé: bénéfice de la réduction des médicaments = Moderate Potentially Drug-induced Hyponatremia in Older Adults: Benefit in Drug ReductionSAINT PAUL, Laure Peyro; MARTIN, Jocelyne; GAILLARD, Cathy et al.Thérapie (Paris). 2013, Vol 68, Num 6, pp 341-346, issn 0040-5957, 6 p.Article

Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric modelsCELLA, Massimo; KNIBBE, Catherijne; DE WILDT, Saskia N et al.British journal of clinical pharmacology. 2012, Vol 74, Num 3, pp 525-535, issn 0306-5251, 11 p.Article

Adaptation de la posologie des antibiotiques chez le patient en surpoids = Dosage of antibiotics in overweight patientsLEMAITRE, F; ANTIGNAC, M; FERNANDEZ, C et al.La Lettre de l'infectiologue. 2011, Vol 26, Num 4, pp 140-144, issn 0296-9009, 5 p.Article